SCHEMBL6997080

SCHEMBL6997080

O=[N+]([O-])c1cc2c(cc1O)CCCCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPK1 P28482 3/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 4/20 0.44
MAPT P10636 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TBXA2R P21731 1/20 0.41
ALDH5A1 P51649 1/20 0.41
ABAT P80404 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999559 1.00 GPR35 (0.44) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL29847105 0.98 GPR35 (0.46) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL306355 0.98 GPR35 (0.46) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL1647316 0.94 GPR35 (0.46) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL9452619 0.83 MAPT (0.41) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL14411992 0.79 SIRT6 (0.43) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL9331116 0.79 MAPT (0.54) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL24869958 0.78 PNMT (0.54) GPR35ALDH1A1MAPK1HPGDTP53
SCHEMBL28069542 0.78 PNMT (0.54) GPR35ALDH1A1MAPK1HPGDTP53
Hydrochloric Acid SCHEMBL9331794 0.77 MAPT (0.52) GPR35ALDH1A1MAPK1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed